| Reference | Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, international extranodal lymphoma study group study. Annals of Oncology 2013 May; 24(5): 1344-51 Link |
| Author(s) | Wirth, M. Gospodarowicz, B.M.P. Aleman, M. Bressel, A. Ng, M. Chao, R.T. Hoppe, C. Thieblemont, R. Tsang, L. Moser, L. Specht, T. Szpytma, A. Lennard, J.F. Seymour and E. Zucca |
| Study | IELSG22 |
| |
| Reference | Role of radiotherapy in patients with early-stage diffuse large B-cell lymphoma of Waldeyer’s ring in remission after anthracycline-containing chemotherapy. Leuk Lymphoma.2013 Jan; 54(1): 62–68 Link |
| Author(s) | M Mian, AJM Ferreri, A Rossi, A Conconi, R Tsang, MK Gospodarowicz, E Oldani, M Federico, S Luminari, EM Pogliani, F Rossini, ME Cabrera, M Martelli, G Gutierrez-Garcia, M Busetto, F Cavalli, E Zucca, A Rambaldi and S Cortelazzo; for the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG23 |
| |
| Reference | Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol. 2013 Jan;160(1):47-52 Link |
| Author(s) | Copie-Bergman C, Wotherspoon AC, Capella C, Motta T, Pedrinis E, Pileri SA, Bertoni F, Conconi A, Zucca E, Ponzoni M, Ferreri AJ |
| Study | IELSG3 |
| |
| Reference | Chlamydophila Psittaci eradication with Doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012 Aug 20;30(24): 2988-94 Link |
| Author(s) | A.J.M. Ferreri, S. Govi, E. Pasini, S. Mappa, F. Bertoni, F. Zaja, C. Montalban, C. Stelitano, M.E. Cabrera, A. Giordano Resti, l. Salvatore Politi, C. Doglioni, F. Cavalli, E. Zucca, M. Ponzoni and R. Dolcetti |
| Study | IELSG27 |
| |
| Reference | Primary bone marrow lymphoma: an uncommon extranodal presentation of aggressive non-hodgkin lymphomas. The American Journal of Surgical Pathology 2012 Feb; 36(2): 296-304 Link |
| Author(s) | Martinez A, Ponzoni M, Agostinelli C, Hebeda KM, Matutes E, Peccatori J, Campidelli C, Espinet B, Perea G, Acevedo A, Mehrjardi AZ, Martinez-Bernal M, Gelemur M, Zucca E, Pileri S, Campo E, Lopez-Guillermo A and Rozman M on behalf of the International Extranodal Lymphoma Study Group |
| Study | IELSG29 |
| |
| Reference | Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group. Hematological Oncology 2012 Sep; 30(3):137-42 Link |
| Author(s) | Nicolosi Guidicelli S, Lopez-Guillermo A, Falcone U, Conconi A, Christinat A, Rodriguez-Abreu D, Grisanti S, Lobetti-Bodoni C, Piffaretti JC, Johnson PW, Mombelli G, Cerny A, Montserrat E, Cavalli F and Zucca E |
| Study | IELSG13 |
| |
| Reference | First-line treatment for primary testicular diffuse large B-cell lymphoma with Rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial. Journal of Clinical Oncology 2011 July; 29(20): 2766-2772 Link PDF (143K) |
| Author(s) | Vitolo U, Chiappella A, Ferreri AJ, Martelli M, Baldi I, Balzarotti M, Bottelli C, Conconi A, Gomez H, Lopez-Guillermo A, Martinelli G, Merli F, Novero D, Orsucci L, Pavone V, Ricardi U, Storti S, Gospodarowicz MK, Cavalli F, Sarris AH, Zucca E |
| Study | IELSG10 |
| |
| Reference | High response rate and improvement of long-term survival with combined treatment modalities in patients with poor-risk primary thyroid diffuse large b-cell lymphoma: an International Extranodal Lymphoma Study Group and Intergruppo Italiano Linfomi study. Leuk Lymphoma. 2011 May; 52(5): 823-832 Link |
| Author(s) | Mian M, Gaidano G, Conconi A, Tsang R, Gospodarowicz MK, Rambaldi A, Rossi A, Oldani E, Federico M, Luminari S, Bellei M, Pogliani EM, Rossini F, Cabrera ME, Martelli M, Lopez-Guillermo A, Busetto M, Cavalli F, Zucca E and Cortelazzo S |
| Study | IELSG23 |
| |
| Reference | CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11). Annals of Hematology 2011 Apr 90(4): 401-408 Link |
| Author(s) | Mian M, Marcheselli L, Luminari S, Federico M, Cantonetti M, Sarris AH, Rossi A, Rambaldi A, Frontani M, Devizzi L, Gianni AM, Busetto M, Berti E, Martinelli G, Tsang RW, Ferreri AJ, Pinotti G, Pogliani E, Zucca E, Cortelazzo S |
| Study | IELSG11 |
| |
| Reference | Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination. Oncologist 2011; 16(3):336-41. Link PDF (100K) |
| Author(s) | Ferreri AJ, Licata G, Foppoli M, Corazzelli G, Zucca E, Stelitano C, Zaja F, Fava S, Paolini R, Franzin A, Politi LS, Ponzoni M, Reni M |
| Study | IELSG20 |
| |
| Reference | Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Annals of Oncology March 2011; 22(3): 689-95 Link |
| Author(s) | Conconi A, Martinelli G, Lopez-Guillermo A, Zinzani PL, Ferreri AJ, Rigacci L, Devizzi L, Vitolo U, Luminari S, Cavalli F, Zucca E |
| Study | IELSG25 |
| |
| Reference | Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: a pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. British Journal of Cancer 2010; 102:673-677 Link PDF (237K) |
| Author(s) | Joerger M, Huitema ADR, Krähenbühl S, Schellens JHM, Cerny T, Reni M, Zucca E, Cavalli F and Ferreri AJM |
| Study | IELSG20 |
| |
| Reference | High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. The Lancet 2009 Oct; 374:1512-20 Link |
| Author(s) | Ferreri AJM, Reni M, Foppoli M, Martelli M, Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G, Ilariucci F, Rossi G, Soffietti R, Stelitano C, Vallisa D, Zaja F, Zoppegno L, Aondio GM, Avvisati G, Balzarotti M, Brandes AA, Fajardo J, Gomez H, Guarini A, Pinotti G, Rigacci L, Uhlmann C, Picozzi P, Vezzulli P, Ponzoni M, Zucca E, Caligaris-Cappio F, Cavalli F, on behalf of the International Extranodal Lymphoma Study Group (IELSG) |
| Study | IELSG20 |
